Plötzlicher Herztod und Prävention/Therapie

Die Thematik plötzlicher Herztod und kardiopulmonale Reanimation berührt Profis und Laien gleichermaßen und wir unternehmen viele Anstrengungen, die Versorgung betroffener Patienten zu verbessern. Gleichzeitig dieses Thema sehr, sehr komplex und es ist oft erstaunlich wie in der Laienpresse aber auch von Profis unscharfe Vorstellungen verbreitet werden. Aus diesem Grund ....
... finde ich einen aktuellen Artikel von Hulleman und das begleitende Editorial höchst interessant:

Hulleman präsentiert Daten aus Holland und stellt dar, wie sich die Inzidenz von "out of hospital cardiac arrest" (OHCA) mit Kammerflimmern bzw. einem nicht-Kammerflimmern-Erstrhythmus entwickelt hat. Die Ergebnisse sind erstaunlich: Die Abnahme eines Schockbaren Rhythmus bei OHCA konnte im Verlauf gezeigt werden und wird auf die Errungenschaft des AICD zurückgeführt. Gleichzeitig nimmt die Inzidenz von nicht-schockbaren Rhythmen als Erstrhythmus eines OHCA signifikant zu. Hierzu gibt es natürlich 1001 verschiedene Erklärungen. Dies können Sie im Originalartikel als auch im Editorial detailliert nachlesen. Auch die zur Prävention eingesetzte medikamentöse Therapie (z.B. Betablocker) könnten hier einen Beitrag geben.

Im begleitenden Editorial wird sehr detailliert auf die verschiedenen Aspekte der Prävention und der Therapie des plötzlichen Herztodes eingegangen. Wirklich lesenswert. Zumindest mir wurde in einigen Aspekten die Augen geöffnet.

Extrem spannend bearbeitetes Thema. Any comments?

World Sepsis Day and a Game to Play

World Sepsis Day is on Thursday the 13th of September.

 

Here is a link to a game to help you learn about sepsis

Septris

 

On World sepsis day follow the conversation on twitter

Twitterchat – an international conversation via Twitter in relation to sepsis.

We will host an international Twitterchat and ask the audience 3 questions

related to sepsis, this will generate a conversation across Twitter. This is a

fantastic opportunity to discuss topics related to sepsis treatment and

management, connect with people interested in similar topics and discuss

strategies to overcome challenges. We will be using the #WSD12, please join in.

Empiric hydroxocobalamin for smoke inhalation: what’s the cost? where’s the evidence?

1.5 out of 5 stars

Empiric Management of Cyanide Toxicity Associated with Smoke Inhalation. O’Brien DJ et al. Prehosp Disaster Med 2011;26:374-382.

Abstract

Whether or not to use empiric hydroxocobalamin to treat victims of smoke inhalation is a hotly debated topic for which all sides agree there is no (and will probably never be any) definitive evidence. A recent editorial in Annals of Emergency Medicine summed up the situation:

The lack of controlled efficacy data for smoke inhalation, combined with uncertainties about safety in patients, make an adequate risk:benefit calculus difficult. A call for routine empiric administration of hydroxocobalamin to smoke inhalation victims seems unwarranted until we have more data. For now, clinicians should assess patients individually and use cautious judgement. It appears reasonable to consider empiric hydroxocobalamin for victims who are comatose, in cardiac arrest, or have clear signs of cardiovascular extremis.

The stated goal of this current study was to “review published and recently presented studies on the empiric prehospital and emergency department treatment of suspected cyanide poisoning in smoke inhalation victims and to develop treatment protocols for clinical use in the US.” Unfortunately, there are absolutely no methods described indicating how relevant literature was identified, evaluated, or reviewed. Nor is there any hint about how the suggested treatment protocols were put together. Suffice it to say that all four authors disclosed that they are or have been affiliated with manufacturers and/or distributors of the Cyanokit.

Thus, I did not find it surprising that the guidelines they came up with call for fairly liberal empiric use of hydroxocobalamin. One aspect they do not discuss is the cost either of supplying ambulances with hydroxocobalamin, or of increased empiric use of the antidote in the emergency department. With the cost of a single treatment running approximately $1000-$2000, and unused antidote having to be replaced at regular intervals, that cost would not be insignificant.

Related posts:

Is the initial lactate level helpful in managing patients with carbon monoxide poisoning?

Potassium cyanide ingestion and hydroxocobalamin

More on Cyanide Antidote Smackdown: Hydroxocobalamin vs. Sodium Nitrite

Antidotes Pearls and Pitfalls

Hydroxocobalamin vs. Sodium Nitrite: Cyanide Antidote Smackdown

What antidotes should my hospital stock?

FOAM(e) IS GOOD FOR YOU!

Just gave a talk on FOAM (or FOAMe as I spelled it) FREE OPEN ACCESS MEDICAL EDUCATION – an acronym coined by Mike Cadogan at the Dublin ICEM 2012 conference.

The legend will state that the idea of FOAM was borne over a pint of Guinness and, like Guinness,  – FOAM is good for you! [To view my Prezi  click here].

The concept of FOAMe came about because Mike felt that the term “social media” when used in an Emergency Medicine context tends to turn people off. This is particularly evident with older generation docs who are picturing some kid with skinny-ass-hanging-out-jeans Tweeting about Kim Kardashian. This is unfortunate, because, in so doing, these docs aren’t benefiting from engaging in this incredible online conversation.

So, like others, I am trying to be an apostle for FOAM … [and I can understand why Mike has found it challenging to speak about].

Why should we engage in FOAM?

  • It’s free.
  • It’s relatively easy to access
  • Once you know how, it’s  an incredibly efficient use of your time.
  • It’s created and curated by the avaunt-guard in your specialty.
  • If you’re NOT doing it … you’re missing out.

I have found Twitter CLINICALLY useful. Additionally there is a constant conversation going on about emergency medicine that you really need to be a part of because guess what? YOU have something to share!

Why NOT to immerse yourself in FOAM?

  • You’re a tech laggard.
  • There’s too much stuff out there.
  • You may have concerns regarding peer review.

Here’s my thoughts about your concerns.

My name is Nadim and I am a luddite. I learned how to have an online presence by being challenged by my peers – you can too.

There IS a lot of great stuff out there. If you just want to follow ONE thing -follow LifeInTheFastLane

Your concerns regarding peer review are valid. Most of the avaunt guard that are out there should have a profile that explains who they are and what they are about. The LifeintheFastLane folks have tried to catalogue some of the great-tasting FOAM out there [click here] … BUT Just like any Journal Article – you need to critically assess what you’re reading. In a short while you will sift through the stuff that you find useful.

I would go one step further and sign up for a Twitter account. Follow some of the folks on the LifeInTheFastLane link above.

Don’t just take my word for it!

Here’s Anne Marie Cunningham’s take on why you should be a Twittering doc

Read Ronan Kavanagh’s blog [click here] -  proof that engaging on the Twitterverse leads to meaningful collegiality and collaboration across international borders.

Here’s Mike’s ICEM2012 Talk on FOAM hosted on the blog of one of my brilliant collegues Andy Neil [click here].

So get out there and sample some FOAM! It has the potential to transform the way you practice – at the very least you will have pushed your envelope a little bit.


Best Sign of Approval

Tweet I have to say that what makes me happiest to hear at work is when a nurse or tech asks me if I’m working overnight and if I answer in the affirmative, they reply “YES!” and pump their fist. I guess they like me. ‘Sniff’

Slides and Videos of #ICEM2012 talks online

If you head over to the ICEM 2012 website they’ve added pdf files of the slide shows of most of the talks from the conference. There are also some videos of the plenary sessions from the mornings.

The videos don’t seem to be embeddable but I’ve arranged them below for direct access if you want them.

Wednesday, 27th June: Welcome Address from President Michael D. Higgins and Plenary: Emergency Medicine Public Health and Policy Making

Click to View

Thursday, 28th June: Clinical Decision Making in Emergency Medicine – Prof. Patrick Croskerry.

Click to View

Friday August 29th: Articles You Should Read – Prof. Richard Cantor and Plenary 2: George Podgorny Lecture – Prof. Peter Cameron

Click to View

Saturday August 30th: Post Cardiac Arrest Syndrome – Prof. Clifton Callaway – Prof. Laurie Morrison / ICEM 2014 Hong Kong Invitation

Click to View

Don’t forget the audio from the entire conference is available on freeemergencytalks.net (cheers Joe!) and LITFL has a nice little post with all the audio of the talks arranged by track and day.


Filed under: ICEM2012

Arboviroses

Une arbovirose est une infection virale transmise par un vecteur qui est un arthropode hématophage (arbovirose pour arthropod-borne virus). Les plus courants sont les moustiques, mais on trouve aussi des phlébotomes (morphologiquement assez proches des moustiques) et des tiques. Les virus concernés ne font pas forcément partie des mêmes familles virales : Flavivirus (dengue, West [...]

Estomatitis Herpética:Cuando una enfermedad simple,puede ser necesario hospitalizar

Existen patologías que para un médico no es complejo reconocer en pocos segundos y decir a la madre del niño "No es nada grave pasará en una semana,tendrá fiebre,es un cuadro viral,llamado Estomatitis herpética" Este niño lleva ya siete días febril,con temperaturas de 39 a 40 grados,presenta estas lesiones bucales,no come y no toma liquidos,pediatra había indicado antitérmicos y antivirales que la madre no pudo comprar.
Visto en Hospital pediatrico ,donde se reitera el "ya va a pasar" sin acoger la angustia de la madre .
Considerando que el menor además presenta factores de riesgos por una enfermedad genética, decido derivar para que se administren los medicamentos requeridos,se hidrate y alimente al menor,sin considerar además los factores sociales familiares Espero que haya sido hospitalizado,ya les contaré


It’s the drugs man!

 

 If you struggle to remember the vast pharmacopeia that sloshes about your ICU and the ring-structure reconstructing part of your brain is less well developed than the average anaesthetic trainee - fear not! In 2010 Kiwi intensivist, Dr Paul Young, put together a Frank Shan-esque book of spells that targeted commonly encountered potions for his unit and then released it as a literary gem.

And instead of waiting for the royalty dollars to come rolling in (Anyone who has published a medical book knows this is a markedly unsuccessful retirement strategy), he let the guys on Life In The Fast Lane publish the entire thing for free.

So the next time you want to refresh a detail on a particular ICU medication, follow this link for almost everything you need to know and nothing that you don't.

{jcomments on}

Unnecessary Testing

Real patient encounter …

A 22 year old guy comes to the registration grabbing his chest. He’s having palpitations and chest pain.

He’s a pack a day smoker, has no family history of heart disease, and was out late the prior evening partying. So when he woke up, he was dragging a little. He had to be at his construction job in an hour, so he drank a “Monster” energy drink. When he got to work, he still felt tired, so he drank another “Monster” energy drink. That’s when the palpitations and chest pain started. He was anxious and felt a little short of breath, too.

The EKG from triage showed a mild sinus tachycardia of 106. No arrhythmia. No ischemia. His physical exam was completely normal except for his anxiety and his elevated pulse. He got an aspirin and some Ativan.

A half hour later, he wasn’t feeling any better even though his pulse was in the 80s.

Now everything points at this guy being acute “Monster” caffeine overdose. It was suggested that he be discharged with a prescription for Ativan and an order to lay off the caffeine. But because he was still symptomatic, he got an entirely unnecessary cardiac workup. His second EKG was normal sinus rhythm and still showed no ischemia. His CBC, chemistries, cardiac enzymes, and urine drug test were all normal.

Oh, and his chest x-ray showed a complete collapse of his left lung.

The problem with labeling testing “unnecessary” – even though the tests may be normal most of the time, they aren’t normal all of the time.

Where do we draw the line between what is and is not “unnecessary”?

---------------

This and all posts about patients may be fictional, may be my experiences, may be submitted by readers for publication here, or may be any combination of the above. Factual statements may or may not be accurate. If you would like to have a patient story published on WhiteCoat's Call Room, please e-mail me.

How Fast Can We Rule-Out AMI?

Six hours?  Two hours?  One hour?  McDonalds' drive-thru?

This is the paper from Archives of Internal Medicine that's been making the rounds in the lay press regarding how quickly the ER should be able to detect your AMI with the new highly-sensitive troponins.  This is the APACE, prospective, international, multi-center study evaluating patients with "symptoms suggestive of acute myocardial infarction" and onset within the last 12 hours.

In this cohort, 1247 patients were recruited - and >300 were excluded for either going straight to the cath lab or having "another procedure performed" at the 1-hour time mark - and received hs-cTnT at index, 1, 2, 3, and 6 hours after presentation.  Myocardial necrosis was defined as a hs-cTnT >99th percentile, which for this assay is 14 ng/L, and a diagnosis of acute MI was made by two independent cardiologists upon review of records and lab results.

The authors split their cohort into two groups, a derivation cohort and a validation cohort, and did some statistical wrangling to come up with two cut-off strategies - one for rule-in and one for rule-out.  They were able to make diagnostic decisions on ~76% of their cohort at the one-hour time point, and 52 ng/L at presentation or an increase within an hour of 5 ng/L or more was ~94% specific for AMI.  Likewise, 12 ng/L and an increase less than 3 ng/L at 1 hour was ~100% sensitive for AMI.  The remaining 25% of their cohort was in a non-diagnostic zone.  At 30 days, there was one death in their rule-out cohort, for a 99.8% survival rate.

So, can you use this strategy?  If you feel as though this study is externally valid to your populations and you're using the same Roche Diagnostics test, you certainly may.  Every piece of data is something you can incorporate to your discussions with a patient regarding diagnostic certainty and risk.  Even an extra hour occupying an ED bed rather than moving out to a chest pain observation facility can significantly impede ED flow, while observation admissions are costly and inconvenient to patients.  The ideal strategy will depend on the capabilities of individual departments.

This study, along with the primary author, are sponsored in part by Abbott, Roche, and Siemens.
www.ncbi.nlm.nih.gov/pubmed/22892889

77 year old female: Unresponsive – Discussion

This is the discussion for 77 year old female: Unresponsive, if you have not read the case report we recommend you start there!

First, a hat tip to our readers who were unafraid to tackle this challenging scenario. Second, we were very impressed to see a number of readers correctly identify this challenging rhythm!

When we left off our crew was attending to an altered 77 year old female they picked up at a local skilled nursing facility. The patient's presentation seemed fairly routine for an Altered Mental Status rule-out.

However, once she was placed on the monitor her status became less clear:

We'll See What Shakes Out - Rhythm Strip

Given the fast rate and possibility for SVT, atrial fibrillation, or even ventricular tachycardia the crew needed more information.

When faced with an uncertain rhythm strip it is best to acquire more leads, and a 12-Lead is a wonderful way to do so:

We'll See What Shakes Out - 12-Lead

So what are we looking at?

  • Many readers pointed out the irregularly irregular tachycardia present in just about every lead.
  • Some readers pointed out the regular rhythm present in lead III.
  • Other readers noted the 3-Lead and 12-Lead were full of artifact.
  • Some readers gave up with cries of, "Treat the Patient! Not the Monitor!"

Ok, I can read the comments; tell me what it is!

The answer is easiest to see in the initial rhythm strip. A closer inspection reveals that when you try to line up Leads II and III, they do not even march out!

We'll See What Shakes Out - Rhythm Strip Marked Up

If we were to display a tracing of the pulse oximetry waveform, it would likely be more evident that only Lead III is providing a useful display.

So why did our patient's pulses not match with her cardiac rhythm?

And why did our patient have an irregular tachycardic rhythm in every lead but Lead III?

Both prehospital and hospital providers who routinely acquire electrocardiograms are familiar with artifact obscuring rhythm and 12-Lead interpretation. Common causes of artifact on the ECG include power line intereference, patient movement, and baseline wander. Lesser known causes of artifact on the ECG include cable failure, neurostimulators, lead placement over arterial pulse points, and electrode manipulation.

Cardiac monitors are designed with electrical filters which screen out intereference which is of a frequency that exists outside the range of physiologic parameters. Unfortunately, if the frequency of an artifact occurs at a near-physiologic rate it will be up to the provider interpreting the ECG to mentally "screen out" the interference.

In this case our patient has advanced Parkinson's disease, which is a degenerative neurological disorder affecting the central nervous system. The most visible symptom of this disease is the motor dysfunction and the characteristic tremors it produces in the periphery. As with any patient motion, it can cause artifact on the surface ECG.

If we take a closer look at Leads II and III we can see that the Parkinsonian Tremors present produced artifact at a rate of 250-300 and looked surprisingly like Atrial Fibrillation with WPW!

We'll See What Shakes Out - Lead II and Lead III

There have been multiple case reports of Parkinsonian Tremors mimicing ventricular tachycardia, ventricular fibrillation, atrial flutter, and supraventricular tachycardia. In one case, a comatose ventilated patient inappropriately received defibrillation for what appeared to be ventricular tachycardia!

When evaluating a patient with tremors it is best to place the leads in the Mason-Likar configuration, i.e. the limb leads are placed on the chest and abdomen. However, sometimes even that will not help and a switch to an anterior-posterior configuration (roughly approximating the pads position, or V4-RA and V8-LL) may be your only option to record a semi-clean tracing.

Remember, as prehospital providers it is important that we be able to explain our findings on the ECG because it may have a large impact on the patient's inhospital care.

Epilogue

Our crew was perplexed as to the discrepancy between the patient's pulse rate and that the rhythms in Leads II and III seemed, "out of sync". They contacted medical control for guidance and were advised to transport to the closest facility and to withold rate control while the patient's blood pressure was adequate.

Narcan was administered due to a persistently low SpO2 and pinpoint pupils. The remainder of the transport was unremarkable and the patient's vital signs remained relatively unchanged. A palpable pulse of 70 was weakly present at the radials while a monitored heart rate of 250-280 was given.

Upon arrival at the receiving facility the patient was noted to have converted to a normal sinus rhythm, with an RBBB and ocasional PVC's. However, during the course of her ED stay she had another "bout of tachycardia" on the monitor and was sent to the floor for observation. It is the opinion of this author that the patient's recurrent tachycardia was merely artifact, likely similar to that seen in her prehospital ECG's.

We hope you enjoyed this case as much as we did!

Not all ST elevation is STEMI – the follow up

So this ECG has generated a fair bit of interest and quite a few comments both here and on Twitter. I trickled out a bit more information in the second post, but here is the final act:

I figured there were essentially three options for this patient (with a few minor variations possible) given that it was midnight and the “cardiology” registrar was a covering respiratory registrar:

1) Activate cath lab
2) Treat like a non-STEMI and consider a cath in the morning
3) Get an Echo looking for regional wall motion abnormalities and use that to guide decision re. primary cath urgently or not

Frankly, I think these are all reasonable options, with only logistical differences. He is a young man, and with his story is going to score a cath at some point anyway – only the timing of it remains to be decided. I thought he had myopericarditis, but that his more severe pain from two days prior sounded suspicious for ischaemic pain, so I wasn’t prepared to ignore that. I toyed with the idea of a late night Echo-tech call-in, but elected to treat him as a non-STEMI-plus, in that he got aspirin, clopidogrel, heparin and in consultation with the very sleepy on-call interventional cardiologist (who I think liked my plan because he got to stay in bed, rather than beacuse of innate superiority to other approaches), a tirofiban infusion. An Echo was organised for the morning and he went to CCU.

Echo report (paraphrased summary):

  • Mildly impaired LV function with two regional wall motion defects (inferoposterior basal and mid segment hypokinesis) with an EF of 50%.
  • There was a tiny posterior effusion.
  • Valves and other chambers NAD other than mild TR.

He not suprisingly went for a cath that morning too:

  • LAD: 70% stenosis, diffuse disease
  • LCx: 100% stenosis
  • Proximal 1st obtuse marginal: 70% stenosis
  • RCA: 60-70% stenosis
  • Conclusion – triple vessel disease, culprit lesion in LCx, akinetic inferior wall

The serial troponins went from 16 to 9 to 6 over the next 24 hours. The patient was discharged and referred for a CABG. The discharge summary prepared by the cardiology resident didn’t mention myopericarditis, but in discussion with the cardiologist himself, it was clear that his opinion was that the patient indeed had myopericarditis secondary to his infarct, which almost certainly occured 2 days prior and correlated with his more severe and typical sounding episode of pain.

This ECG from just before his cath and Echo is much more consistent with myopericarditis, with widespread saddle-morphology ST elevation, PR depression, and PR elevation in aVR:

So there you have it – a late-presenting MI (perhaps STEMI?) AND myopericarditis. This syndrome of early post-MI pericarditis may be rarer in the post-thrombolysis/PCI era, and is also known as PIP or PAMISP. It’s a bit too early for the autoimmune mediated Dressler’s syndrome (which is definitely rare in the post-interventional era), as suggested by some commenters, which tends to kick in from around 2 weeks post-MI. From emedicine on the topic:

“The incidence of early pericarditis after MI is approximately 10%, and this complication usually develops within 24-96. Pericarditis is caused by inflammation of pericardial tissue overlying infarcted myocardium. The clinical presentation may include severe chest pain, usually pleuritic, and pericardial friction rub.

The key ECG change is diffuse ST-segment elevation in all or nearly all of leads. Echocardiography may reveal a small pericardial effusion. The mainstay of therapy usually includes aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs). Colchicine may be beneficial in patients with recurrent pericarditis.”


Preparing for the exam? Check out the Emergency Care Institute.

Founded by ACEM luminary Sally McCarthy, the New South Wales Emergency Care Institute (ECI) is a great resource for those of you preparing for the exam.

Click on the "Doctors" tab in the slider-menu, and have a look at their Clinical Tools.  There you'll find a wealth of clinical guidelines (mostly from NSW Health) and even links to some useful apps.  

There's a "Top 20 Sites" page (which EDExam features on!), showcasing the top Emergency Medicine online education resources, as well as a section on Clinical Education and Training with links to various courses.  There's some quick reference guides to various bits of ED equipment as well.

There is still no "one stop shop" when it comes to Emergency Medicine webucation, but the ECI site has a lot of great, local information for those of you preparing for the ACEM Fellowship exam, and I recommend you check it out.

Nurses under pressure in Hong Kong.

An article in the China Daily highlights the acute shortage of nurses being experienced in in Hong Kong.
A recent survey of 2,180 public sector nurses reported a ratio of one nurse to every 10 or 11 patients.

In their emergency departments the ratio was as low as one nurse to every 14 patients. Yipes.

Pretty concerning. Especially when you consider the manager to nurse ratio suggested by the accompanying photo.
Five clipboard wielding managers assessing the exactitudes of the hospital corners being performed by one nurse.

And I thought we were under pressure!

You can read the whole article here.

Online study: Clinical Leadership.

Deakin University is offering a new masters course in clinical leadership that on first blush looks a bit useful for anyone aspiring to a senior clinical position in their workplace.

This Master's program is designed to provide senior clinicians with the skills and breadth of understanding that they need in order to undertake leadership roles within the Australian Healthcare system. The program is being offered widely but Deakin is committed to ensuring that the program is relevant to Australia's clinical leaders. The program will be offered largely on line, with the Clinical Leadership components being taught and experienced in a series of intensive residential programs conducted over the course of a year. These programs will bring together industry leaders and students in a high quality learning environment with a focus on leadership for system, organisational and care delivery improvement.

Units:

  • Clinical Leadership 1: System and Strategy
  • Clinical Leadership 2: the Organisation
  • Clinical Leadership 3: Clinicians Consumers and Their System
  • Contemporary Health Issues and Policies
  • Health Economics 1
  • Financial Reporting and Analysis
  • Strategic Management

Core selective units – students must enrol in one of the following list:

  • Human Resource Strategy
  • Corporate Governance and Ethics
  • Marketing Management
  • Business Process Management
  • Audacious Leadership
  • Organisational Behaviour
  • Human Resource Management
  • Change Management

Applicants must be clinicians who hold Bachelor level qualifications from an Australian university or Higher Education Institution recognised by the Australian Qualifications Framework.

The next intake is in November, and the course runs 12months full time or part time equivalent.

Interested? You can find out more here.

Coming Soon – World Sepsis Day


Liebe Kolleginnen und Kollegen

gerne unterstütze ich den Weltsepsistag, der in Zusammenarbeit mit der Gruppe von Prof. Reinhart aus Jena, organisiert wird.


Bitte beachten Sie das Video dieser Aktion.

Außerdem kopiere ich Ihnen hier eine eMail von Prof. Reinhart mit der Bitte um Beachtung. Unsere Klinik ist bereits registriert. Machen Sie mit! 

Dear colleagues and supporters of World Sepsis Day,

as September 13th is approaching fast, in the following please find a short update on our current status/activities.

Supporter
As you may also depict from World Sepsis Day  website during the last weeks numerous additional professional national societies and international organizations have joined the coalition of supporters for  the WSD, among them the intensive care societies from Austria, Brasil, Poland, Serbia, Spain, the Canadian and Scandinavian Critical Care Trials Group, and the George Institute. Additionally we received support from organisations from Nigeria and Kenya.
Our supporters come from 52 nations and so far 144 Supporting organizations, 495 Healthcare Workers, 596 Organizations providing healthcare which represent over 800 hospitals and 121 private individuals declared their support. This list is growing daily. Currently, we receive approx. 38 new registrations per day.

Ø  Please continue to encourage societies, groups, hospitals and corporate groups to become supporters of the WSD

The International Association of Medical Students put sepsis and World Sepsis Day on their agenda during their recent annual meeting in Mumbai to promote the movement in their community.

Upcoming Events
It is also great that we have friends and supporters that organize events on all continents for example in South and North America (Peru, Columbia, Chile, Brasil, USA, Canada), in Asia (China, India, Pakistan and Korea, the Pan Arabic region), Africa and Europe.

Ø  Please let us know asap what events you are planning.
To support your event planning and communication we recommend that you register your event on the World Sepsis Day website via your log in.
In case we should do this for you please provide us with the following information:
- Name of the event
- Location
- Date and starting Time 
- A short description of your event
- Contact email address
- Picture of your location (please at least 300k)

Ø  You may also download the toolkits from the website for your activities that we are about to update continuously in the next weeks.
Ø  Also we provide you with a small animation on sepsis as an emergency: http://www.youtube.com/watch?v=MDXUNn7yRvQ&feature=plcp
Please feel free to watch, distribute or embed it into your website or communication

Sponsors
We are very glad to have received sponsoring from the following organisations: considerable funds were provided by the German Sepsis Society and the Jena Center for Sepsis Control and Care for the establishment of the WSD website, the production of the toolkits, promotional materials and managerial support; the GSA received some financial support by Thermo Fisher Scientifc, as Gold sponsor and by BBraun and Roche Diagnostics as Bronze sponsors; smaller funds were obtained by Adrenomed Berlin, CLS Behring, and Biomerieux.

Furthermore, we received support for the sepsis light events in Berlin, London and Jena porcelain manufacturers Rosenthal Germany and Kahla Porcelain Germany who provide  over 2000 beautiful porcelain windlights.

Please note that parts of the design and communication work is provided by Lindgruen pro bono. The Berlin Charity Event is made possible by the generous financial support of a number of German colleagues from the field of intensive care medicine.

Ø  As we should acknowledge the supporters of national and local events on the WSD website, please provide us with this information where applicable and inform your sponsors (private individuals, public  foundations and corporate firms) about this option.

Overall we can be very proud of what we have achieved together so far, because this effort is driven by the medical and scientific community and has set free so many excellent ideas and activities by  many societies, groups and individuals.

Thanks to all of you and the best wishes for your activities on September 13th.

Best regards,

Konrad Reinhart


__________________________________
Prof. Dr. Konrad Reinhart
Director of
Dep. for Anaesthesiology and Intensive Care
Chairman Global Sepsis Alliance
Erlanger Allee 101
07747 Jena
Germany

Phone +49 3641 9323101/11
Fax +49 3641 9323102/12
Cell phone +49 171 7535823
E-Mail 
konrad.reinhart@med.uni-jena.de

Ipertensione lieve:i farmaci servono?

Nella scheda di triage della paziente che mi appresto a visitare vedo scritto crisi ipertensiva e a fianco la rilevazione dei valori pressori 155/95. La gestione di queste situazioni non è mai...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

ECG of the Week – 20th August 2012 – Interpretation

This ECG is from a 12 day old boy.









Click to enlarge
  • ECG taken at 50 mm/s (usual paper speed is 25 mm/s)
  • V4-6 not on ECG Paper

Rate:
  • ~310
  • As 50 mm/s Rate = number of big squares between R-R complex divided into 600 (or)
  • As 50 mm/s Rate = number of small squares between R-R complex divided into 3000
Rhythm:
  • Regular
  • Nil P Waves Visible
Axis:
  • RAD (105 deg)
Intervals:
  • PR - Nil p waves visible
  • QRS - Narrow (40ms)
  • QT - 140ms
Additional/Segment:
  • Incomplete Precordial Leads Limit Interpretation
Interpretation:
  • Narrow Complex Tachycardia / SVT
Causes

  • ~50% of Paediatric SVTs have no underlying heart disease
  • Can be secondary to fever & drugs
  • ~25% of Paediatric SVTs have congential heart disease
  • ~25% of Paediatric SVTs have WPW
Read more on Paediatric ECGs -Normal and Abnormal here



Below is an ECG taken on the same patient at standard calibration (25mm/s)

Click to enlarge
References / Further Reading


Life in the Fast Lane

  • Paediatric ECG Interpretation here
  • SVT here
Textbook
  • Chan TC, Brady WJ, Harrigan RA, Ornato JP, Rosen P. ECG in Emergency Medicine and Acute Care. Elsevier Mosby 2005.

Clinical Case 063: Ultra-sounds like pneumonia to me

A few months ago I posted on the use of US for diagnosing pneumonia.  Check out that post here.  I have been trying it out since, but haven’t seen a good going fresh pneumonia for a while…..

Since then the guys at Ultrasound podcast have released an awesome lecture by Vicki Noble on the same – it is 30 minutes well spent for anyone who wants to use US and change the way they approach dyspnoea in the ED.

Today we saw a sick kid with “a bit of a cough” who had good going consolidation on US of the chest and on CXR.  So I am putting up the images for you all to see.  It is a simple technique – just put the probe where you would usually put your bell and look for detail of lung, fluid collections, air bronchograms and “hepatisation” behind the white pleura.

It is quick, no radiation, painless, and easy to do at any hour of the day or night.

Sure, there is a learning curve.  Takes time to train the eyes and be confident, however the result is a pretty clear diagnosis to guide therapy and disposition decisions.  I think that in time, one can get good enough to pick pneumonia early and avoid some X-rays.  US compares well with plain films in terms of accuracy – but it leaves the stethoscope for dead – so I think I will use it when I am looking for a source in a sick patient, or when my exam is equivocal in a well looking patient.  Any thoughts on this?

 

Pretty clear cut left lingula consolidation with some bronchograms. 

Shows lung detail below the pleura which usually obscures any details. Left pneumo (Click to open video clip) 

If you are not familiar with chest US – this is a wildly abnormal image – usually no detail of the lung architecture can be seen below the pleura.

For a great demonstration of this check out the above mentioned US Podcast talk.  Matt and Mike pay me $20 everytime one of you click on their site – hurry and check it out – I think they are offering a prize for their 100th visitor.  Enjoy

Casey

 

 

 

 

 

 

 

 

 

 

 

 

EM Board and Inservice Review

One of the things you will be seeing in the upcoming weeks and months is the addition of board/inservice exam review content.  I will be making some board review podcasts, and will also be posting some questions here on the blog.  My hope is for interaction, so feel free to answer questions, post questions, and interact.  

One disclaimer: all questions that I post on the blog are ones that I made up.  I will not be posting questions from any books, nor do these questions come directly from the Emergency Medicine Boards.  My goal is to emphasize what I found to be important points in my studying and review, as well as conceptual approaches to studying for the exam.  I will not be posting anything that is not free public knowledge about the exams already.  Do not expect insider information.  Since I am making these up, do not expect them to necessarily be board level quality.  Basically, I’m not doing anything against the rules!

First question:

A 65 year old make with a history of hypertension and a 50 pack year history of smoking presents s/p syncope and abdominal pain.  On exam, his HR is 110/min, BP 82/40, RR 16, and Pox 98% on RA.  You note abdominal tenderness in the midline, and a palpable pulsitile abdominal mass on exam.  What is your next step in the management of this patient?

A.  Arteriogram

B.  CT scan of the abdomen and pelvis with IV contrast

C.  MRI of the abdomen

D.  Point of care ultrasound of the abdomen 

living in the hospital fantasy world

I work in the land of make believe. Its a place where everybody pretends things are different than they really are. There are beings here who run this land of make believe. They are the ones who make the rules. Lets call them the rulers.

The rulers like to get together and think up new rules and change the rules they already made. That's what they get paid to do. They send the rules and changes they have thought of down to another group of people who deliver the rules, make sure the rules are followed. Lets call them the enforcers.

The people who receive the rules and changes and have to live by them are at the bottom of the pyramid of make believe land. They are the people who actually try to follow the rules as they do the work. Lets call them the nurses.

Here's the thing. The rules that the rulers make, and the enforcers enforce are rules that nobody can ever follow. There are too many rules, they keep changing. The nurses can't possibly follow the rules. There are too many. Its impossible to keep up with them. The changes are too numerous and often make things more complicated.

So the nurse eventually give up. They tell each other, forget it. I'm not even going to try and follow the rules. There is no point. I can't keep up. I'm just going to follow the rules I can and screw the rest.

Moral of the story: If you keep changing policies, increasing charting requirements, making things more complicated, the nurses will just do what they can and you won't get what you want. And when the rulers of the rulers, the kings and queens of make believe JCAHO) appear, everybody will be screwed.
)

Case Report: fatal GI bleed 6 days after one dose of dabigatran (Pradaxa)

3 out of 5 stars

Fatal gastrointestinal hemorrhage after a single dose of dabigatran. Kernan L et al. Clin Toxicol 2012;50:571-573.

Abstract

The RE-LY trial, the major study evaluating use of dabigatran etexilate (Pradaxa) as an anticoagulant to prevent stroke in patients with atrial fibrillation, excluded subjects with creatinine clearance less than 30 ml per minute. Since elderly patients frequently have undetected renal insufficiency, sometimes with normal creatinine levels, this population is at increased risk for major bleeding when taking this drug. In fact, in the European Union, the manufacturer recommends that patients older than 75 years of age have renal function tested before being put on dabigatran and regularly thereafter.

This somewhat puzzling case report reinforces this point. A 92-year-old man took an initial 150-mg dose of dabigatran at 10 pm. He awoke the next day with significant bleeding per rectum. On presentation to hospital 11 hours after ingestion, he was hypotensive (62/30 mmHg) and anemic (hemoglobin = 9.9 g/dL). His creatinine clearance at that time was 24.2 ml per minute; apparently,  previously it was 33.9.

The patient was resuscitated and an actively bleeding gastric ulcer seen on endoscopy was treated with local epinephrine injections. On hospital day 3 he appeared stable. However, on day 6, gastrointestinal hemorrhage recurred, and despite treatment the patient died the following day.

I’m not sure I’m convinced that -- even given the patient’s renal insufficiency -- the single dose of dabigatran was responsible for the fatal GI bleed 6 days later. Even with the reduced creatinine clearance, I would expect most of the drug to be gone by that time. Although dabigatran is cleared predominantly by the kidneys, the major problem in renal failure would be increased levels as drug accumulates with repeated dosing. Unfortunately, no drug level was measured in this case. Nevertheless, the authors make some points worth considering:

  • “The RE-LY trial demonstrated a significantly higher risk of gastrointestinal bleeding in the dabigatran group (17% dabigatran vs. 6% warfarin).”
  •  The fact that the patient was on steroids and the proton-pump inhibitor omeprazole should have raised concern about increased risk of GI bleeding.

The authors recommend that “baseline renal function and occult stool studies should be performed prior to ignition of [dabigatran].”

Related posts:

Dabigatran: is laboratory monitoring really unnecessary?

Dabiagtran and the trauma patient

Dabigatran Toxicity: The Top 10 Questions

Review: the bleeding patient on dabigatran

Dabigatran and the elderly

Dabigatran etexilate: a new challenge for emergency physicians and toxicologists

 

Clinical Examination Video Database

The next crop of climbers taking on Mt FACEM are no doubt starting to experience the impending doom of the clinical exams as they creep closer and closer.

Hopefully the latest LITFL database will help alleviate some of this understandable angst.

We’ve created a collection of free online videos featuring demonstrations of systematic approaches to physical examination as well as short videos showing individual physical signs. They are helpful for novice practitioners as well as those brushing up their skills in readiness for a Fellowship grilling.

So click here to go to the LITFL ‘Clinical Examination’ page and search over 150 useful videos!

If you know of other great free online videos that should be in this database for anyone and everyone to use, leave a comment with your suggestion.

(Remember to check the database to see if it’s there first…)

Vive la FOAM!

The post Clinical Examination Video Database appeared first on Life in the Fast Lane medical education blog.